Zenas Biopharma Inc (ZBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2023 | 12-2022 | |
| Cash Flows From Operating Activities | ||
| Net Income | -12,537 | -119,282 |
| Depreciation Amortization | 83 | 78 |
| Accounts payable and accrued liabilities | -3,538 | N/A |
| Other Working Capital | -15,606 | 7,967 |
| Other Operating Activity | 16,469 | 45,585 |
| Operating Cash Flow | $-15,129 | $-65,652 |
| Cash Flows From Investing Activities | ||
| PPE Investments | N/A | -198 |
| Net Acquisitions | N/A | -2,000 |
| Investing Cash Flow | $N/A | $-2,198 |
| Cash Flows From Financing Activities | ||
| Debt Repayment | 20,000 | N/A |
| Common Stock Issued | 66 | N/A |
| Other Financing Activity | 0 | 59,391 |
| Financing Cash Flow | $20,066 | $59,391 |
| Exchange Rate Effect | 165 | -41 |
| Beginning Cash Position | 67,295 | 75,795 |
| End Cash Position | 72,397 | 67,295 |
| Net Cash Flow | $5,102 | $-8,500 |
| Free Cash Flow | ||
| Operating Cash Flow | -15,129 | -65,652 |
| Free Cash Flow | -15,129 | -65,652 |